A chondroitin sulfate proteoglycan 4‑specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model-Reference-Cited by-同舟云学术

A chondroitin sulfate proteoglycan 4‑specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model

Published:2021-07-26 Issue:3 Volume:59 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Uranowska Karolina¹,Samadaei Mahzeiar²,Kalic Tanja¹,Pinter Matthias²,Breiteneder Heimo³,Hafner Christine¹

Affiliation:

1. Department of Dermatology, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, A-3100 St. Poelten, Austria

2. Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, A-1090 Vienna, Austria

3. Institute of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, A-1090 Vienna, Austria

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic potential of exosomal extracellular vesicles in oncology;BMC Cancer;2024-03-08

2. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-01

3. Immunohistochemical detection of the chondroitin sulfate proteoglycan 4 protein in primary and metastatic melanoma;Oncology Letters;2023-07-20

4. Exogenous Recombinant N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B; ARSB) Inhibits Progression of B16F10 Cutaneous Melanomas and Modulates Cell Signaling;2023-05-31

5. CSPG4 expression in soft tissue sarcomas is associated with poor prognosis and low cytotoxic immune response;Journal of Translational Medicine;2022-10-11